<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
TLSA
Tiziana Life Sciences
$
()


  • Tiziana Life Sciences receives $3.4M in non-dilutive funding

    6/28/2024 - 11:20am
  • Tiziana Life to dose first patient with moderate Alzheimer's with foralumab

    6/26/2024 - 07:07am
  • Tiziana Life Sciences receives Fast Track Designation for treatment of na-SPMS

    6/11/2024 - 08:02am
  • Tiziana Life Sciences announces results for na-SPMS patients enrolled in EAP

    6/6/2024 - 09:06am
  • Tiziana Life Sciences submits grant application to ALS Association

    6/4/2024 - 09:17am
  • Tiziana Life Sciences files ODD for intranasal foralumab

    5/13/2024 - 07:16am
  • Biotech Alert: Searches spiking for these stocks today

    4/26/2024 - 10:52am
  • Tiziana Life Sciences reports three-month neuroimaging scores in MS patients

    4/25/2024 - 10:04am
  • Tiziana Life announces FDA allowance for more patients to na-SPMS EA program

    4/23/2024 - 07:11am
  • Tiziana Life Sciences announces additional clinical improvements in EAP

    4/22/2024 - 07:21am
  • Tiziana Life Sciences announces study results on foralumab published

    4/19/2024 - 07:02am
  • Tiziana Life Sciences announces new PET imaging data on foralumab

    4/18/2024 - 07:10am
  • Tiziana Life Sciences to present at AD/PD of nasal anti-CD3 in Alzheimer's

    3/5/2024 - 07:01am
  • Tiziana Life Sciences announces updated clinical, PET scan findings

    1/8/2024 - 07:53am
  • Tiziana Life files new patent application related to GLP-1ra, foralumab

    1/5/2024 - 07:02am
dynamic_feed Breaking News